Acorda Therapeutics
Biotech company strengthens patent portfolio on neuregulins products
Published in Medical Patent Law Weekly, August 10th, 2005
This patent covers compositions of matter for the NRG2 family of growth factors as well as methods of production for NRG2. The addition of this patent broadens Acorda's existing neuregulin portfolio. NRG2 has potential applications in multiple sclerosis, spinal cord injury, Parkinson disease and chronic heart failure. The company plans to continue to file patents in support of the neuregulins program.
The neuregulins are a class of naturally-occurring protein growth factors, which have multiple effects on the nervous system and potential therapeutic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Chromos Molecular Systems, Inc.
ACE System developer strengthens IP estate with four new patents - Cook Biotech
Federal jury rules against ACell in patent infringement verdict - Digene Corp.
Company announces settlement, license agreement with Georgetown - Health Discovery Corp.
Company announces multiple patents covering SVM methods - Protein Polymer Technologies, Inc.
Biotechnology device company announces intention to acquire Surgica Corporation - SPO Medical Inc.
Biosensor, microproccessor developer completes reverse acquisition transaction - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
